Frameshift mutagenesis by 9-aminoacridine, ICR191, AMSA and related experimental antitumour acridines in recA+ and recA1 strains of Salmonella typhimurium
- 1 March 1983
- journal article
- research article
- Published by Elsevier in Mutation Research/Genetic Toxicology
- Vol. 116 (3-4) , 289-296
- https://doi.org/10.1016/0165-1218(83)90066-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The relationship between frameshift mutagenicity and DNA-binding affinity in a series of acridine-substituted derivatives of the experimental antitumour drug 4′-(9-acridinylamino)methanesulphonanilide (AMSA)Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1981
- Inhibition of T4 bacteriophage yield by 9-anilinoacridines; comparison with in vivo antitumour activityPublished by Elsevier ,1980
- 4′-(9-Acridinylamino) Methanesulfon-m-Anisidide (AMSA): A New Drug Effective in the Treatment of Adult Acute LeukemiaAnnals of Internal Medicine, 1980
- Segregation of the mutator property of plasmid R46 from its ultraviolet-protecting propertyMolecular Genetics and Genomics, 1979
- Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity testMutation Research/Environmental Mutagenesis and Related Subjects, 1975
- Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustardsJournal of Medicinal Chemistry, 1972